Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
69
BSY Quote, Financials, Valuation and Earnings
Last price:
$57.60
Seasonality move
:
-4.98%
Day range:
$57.34 - $57.97
52-week range:
$36.51 - $57.97
Dividend yield:
0.45%
P/E ratio:
72.89x
P/S ratio:
13.87x
P/B ratio:
15.92x
Volume:
1.4M
Avg. volume:
1.9M
1-year change:
15.72%
Market cap:
$17.5B
Revenue:
$1.4B
EPS (TTM):
$0.79
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $801.5M | $965M | $1.1B | $1.2B | $1.4B | |
| Revenue Growth (YoY) | 8.81% | 20.4% | 13.89% | 11.77% | 10.15% | |
| Cost of Revenues | $167.2M | $216.5M | $237M | $266.1M | $257.8M | |
| Gross Profit | $634.4M | $748.5M | $862.1M | $962.3M | $1.1B | |
| Gross Profit Margin | 79.15% | 77.56% | 78.44% | 78.34% | 80.95% | |
| R&D Expenses | $185.5M | $220.9M | $257.9M | $274.6M | $281.2M | |
| Selling, General & Admin | $257.2M | $407.4M | $354.5M | $418.7M | $477.9M | |
| Other Inc / (Exp) | $24.3M | $10M | $24.3M | -$7.2M | $12.9M | |
| Operating Expenses | $458.1M | $653.9M | $653.5M | $731.8M | $793.2M | |
| Operating Income | $176.3M | $94.6M | $208.6M | $230.5M | $302.2M | |
| Net Interest Expenses | $32.9M | $11.2M | $34.6M | $39.8M | $22M | |
| EBT. Incl. Unusual Items | $167.6M | $93.3M | $198.3M | $183.5M | $293.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $38.6M | -$3.4M | $21.3M | -$143.2M | $58.7M | |
| Net Income to Company | $126.5M | $93.2M | $174.8M | $326.8M | $234.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $354K | |
| Net Income to Common Excl Extra Items | $126.5M | $93.2M | $174.8M | $326.8M | $234.8M | |
| Basic EPS (Cont. Ops) | $0.44 | $0.30 | $0.57 | $1.05 | $0.75 | |
| Diluted EPS (Cont. Ops) | $0.42 | $0.30 | $0.55 | $1.00 | $0.72 | |
| Weighted Average Basic Share | $289.9M | $305.7M | $309.2M | $312.4M | $314.9M | |
| Weighted Average Diluted Share | $299.4M | $314.6M | $331.8M | $332.5M | $333.8M | |
| EBITDA | $211M | $157.6M | $304.9M | $296.7M | $382.4M | |
| EBIT | $174.8M | $104.9M | $233.3M | $224.9M | $317.8M | |
| Revenue (Reported) | $801.5M | $965M | $1.1B | $1.2B | $1.4B | |
| Operating Income (Reported) | $176.3M | $94.6M | $208.6M | $230.5M | $302.2M | |
| Operating Income (Adjusted) | $174.8M | $104.9M | $233.3M | $224.9M | $317.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $222M | $275.5M | $314.4M | $337.8M | $370.5M | |
| Revenue Growth (YoY) | 14.03% | 24.1% | 14.12% | 7.43% | 9.71% | |
| Cost of Revenues | $49.3M | $55.8M | $67.2M | $61.8M | $65.7M | |
| Gross Profit | $172.7M | $219.7M | $247.2M | $275.9M | $304.9M | |
| Gross Profit Margin | 77.8% | 79.75% | 78.63% | 81.69% | 82.28% | |
| R&D Expenses | $47.8M | $61.3M | $67.8M | $68.4M | $72.5M | |
| Selling, General & Admin | $65.8M | $92M | $103.1M | $106.7M | $109M | |
| Other Inc / (Exp) | $14.5M | $10.3M | $289K | $7.1M | $449K | |
| Operating Expenses | $117.1M | $163.1M | $181.4M | $184M | $189.7M | |
| Operating Income | $55.6M | $56.6M | $65.8M | $91.9M | $115.2M | |
| Net Interest Expenses | $2.3M | $6.7M | $11.1M | $6.5M | $3.8M | |
| EBT. Incl. Unusual Items | $67.8M | $60.2M | $55M | $92.5M | $111.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10.4M | $3.2M | $9.5M | $22.2M | $20.5M | |
| Net Income to Company | $57M | $56.4M | $45.5M | $70.3M | $91.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $30K | |
| Net Income to Common Excl Extra Items | $57M | $56.4M | $45.5M | $70.3M | $91.4M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.18 | $0.15 | $0.22 | $0.29 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.18 | $0.14 | $0.22 | $0.28 | |
| Weighted Average Basic Share | $302.6M | $308M | $310.8M | $314.3M | $315.1M | |
| Weighted Average Diluted Share | $321.7M | $331.3M | $331.3M | $333.6M | $333.4M | |
| EBITDA | $79.2M | $84.2M | $84.4M | $116.2M | $131.9M | |
| EBIT | $70.2M | $67M | $66.3M | $99.9M | $116.2M | |
| Revenue (Reported) | $222M | $275.5M | $314.4M | $337.8M | $370.5M | |
| Operating Income (Reported) | $55.6M | $56.6M | $65.8M | $91.9M | $115.2M | |
| Operating Income (Adjusted) | $70.2M | $67M | $66.3M | $99.9M | $116.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $828.9M | $1B | $1.1B | $1.3B | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $179.2M | $223M | $248.4M | $260.7M | $261.6M | |
| Gross Profit | $649.7M | $795.5M | $889.6M | $991M | $1.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $188.2M | $234.4M | $264.4M | $275.2M | $285.3M | |
| Selling, General & Admin | $260.2M | $433.5M | $365.6M | $422.2M | $480.3M | |
| Other Inc / (Exp) | $46.1M | $5.8M | $14.2M | -$374K | $6.3M | |
| Operating Expenses | $463.7M | $700M | $671.8M | $734.3M | $798.9M | |
| Operating Income | $186M | $95.5M | $217.8M | $256.7M | $325.4M | |
| Net Interest Expenses | $33.8M | $15.7M | $39M | $35.2M | $19.3M | |
| EBT. Incl. Unusual Items | $198.2M | $85.7M | $193.1M | $221.1M | $312.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $41.8M | -$10.6M | $27.5M | -$130.5M | $57M | |
| Net Income to Company | $153.9M | $92.6M | $163.9M | $351.6M | $255.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $30K | |
| Net Income to Common Excl Extra Items | $153.9M | $92.6M | $163.9M | $351.6M | $255.8M | |
| Basic EPS (Cont. Ops) | $0.53 | $0.30 | $0.53 | $1.12 | $0.81 | |
| Diluted EPS (Cont. Ops) | $0.52 | $0.28 | $0.51 | $1.07 | $0.79 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $243.2M | $162.7M | $308.6M | $330.7M | $399.9M | |
| EBIT | $206.1M | $101.7M | $236.3M | $260.5M | $336M | |
| Revenue (Reported) | $828.9M | $1B | $1.1B | $1.3B | $1.4B | |
| Operating Income (Reported) | $186M | $95.5M | $217.8M | $256.7M | $325.4M | |
| Operating Income (Adjusted) | $206.1M | $101.7M | $236.3M | $260.5M | $336M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $222M | $275.5M | $314.4M | $337.8M | $370.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $49.3M | $55.8M | $67.2M | $61.8M | $65.7M | |
| Gross Profit | $172.7M | $219.7M | $247.2M | $275.9M | $304.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $47.8M | $61.3M | $67.8M | $68.4M | $72.5M | |
| Selling, General & Admin | $65.8M | $92M | $103.1M | $106.7M | $109M | |
| Other Inc / (Exp) | $14.5M | $10.3M | $289K | $7.1M | $449K | |
| Operating Expenses | $117.1M | $163.1M | $181.4M | $184M | $189.7M | |
| Operating Income | $55.6M | $56.6M | $65.8M | $91.9M | $115.2M | |
| Net Interest Expenses | $2.3M | $6.7M | $11.1M | $6.5M | $3.8M | |
| EBT. Incl. Unusual Items | $67.8M | $60.2M | $55M | $92.5M | $111.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10.4M | $3.2M | $9.5M | $22.2M | $20.5M | |
| Net Income to Company | $57M | $56.4M | $45.5M | $70.3M | $91.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $30K | |
| Net Income to Common Excl Extra Items | $57M | $56.4M | $45.5M | $70.3M | $91.4M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.18 | $0.15 | $0.22 | $0.29 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.18 | $0.14 | $0.22 | $0.28 | |
| Weighted Average Basic Share | $302.6M | $308M | $310.8M | $314.3M | $315.1M | |
| Weighted Average Diluted Share | $321.7M | $331.3M | $331.3M | $333.6M | $333.4M | |
| EBITDA | $79.2M | $84.2M | $84.4M | $116.2M | $131.9M | |
| EBIT | $70.2M | $67M | $66.3M | $99.9M | $116.2M | |
| Revenue (Reported) | $222M | $275.5M | $314.4M | $337.8M | $370.5M | |
| Operating Income (Reported) | $55.6M | $56.6M | $65.8M | $91.9M | $115.2M | |
| Operating Income (Adjusted) | $70.2M | $67M | $66.3M | $99.9M | $116.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $122M | $329.3M | $71.7M | $68.4M | $64M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $190M | $235.3M | $287.1M | $293.5M | $314.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $3.5M | $16.9M | $18.4M | $12.8M | $13.1M | |
| Other Current Assets | $24.7M | $34.3M | $38.7M | $44.8M | $50.5M | |
| Total Current Assets | $340.3M | $615.8M | $415.9M | $419.6M | $442.1M | |
| Property Plant And Equipment | $74.5M | $82.6M | $72.5M | $78.6M | $66.1M | |
| Long-Term Investments | $5.7M | $6.4M | $22.3M | $23.5M | $25.8M | |
| Goodwill | $581.2M | $1.6B | $2.2B | $2.3B | $2.4B | |
| Other Intangibles | $45.6M | $245.8M | $292.3M | $248.8M | $214M | |
| Other Long-Term Assets | $39.5M | $48.6M | $72.2M | $67.3M | $86.4M | |
| Total Assets | $1.1B | $2.7B | $3.2B | $3.3B | $3.4B | |
| Accounts Payable | $16.5M | $16.5M | $15.2M | $18.1M | $16.5M | |
| Accrued Expenses | $25M | $35.1M | $41.6M | $46.1M | $38M | |
| Current Portion Of Long-Term Debt | -- | $5M | $5M | $10M | -- | |
| Current Portion Of Capital Lease Obligations | $16.6M | $17.5M | $14.7M | $11.6M | $11.7M | |
| Other Current Liabilities | $113.9M | $172.2M | $204.7M | $287.9M | $366.9M | |
| Total Current Liabilities | $465.6M | $593.9M | $628.4M | $760.4M | $814.3M | |
| Long-Term Debt | $246M | $1.4B | $1.8B | $1.5B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $784.4M | $2.3B | $2.6B | $2.4B | $2.4B | |
| Common Stock | $2.7M | $2.8M | $2.9M | $3M | $3M | |
| Other Common Equity Adj | -$26.2M | -$91.8M | -$89.7M | -$85M | -$104.1M | |
| Common Equity | $341.6M | $409.2M | $572.8M | $883.3M | $1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $704K | $704K | $133K | |
| Total Equity | $341.6M | $409.2M | $573.5M | $884M | $1B | |
| Total Liabilities and Equity | $1.1B | $2.7B | $3.2B | $3.3B | $3.4B | |
| Cash and Short Terms | $122M | $329.3M | $71.7M | $68.4M | $64M | |
| Total Debt | $246M | $1.4B | $1.8B | $1.5B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $569.5M | $129.6M | $93.6M | $141.6M | $83.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $183.2M | $225.5M | $277.2M | $274.5M | $303.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $4M | $26.3M | $21.2M | $10.9M | $8.8M | |
| Other Current Assets | $25.1M | $32.6M | $39.8M | $46.7M | $50.1M | |
| Total Current Assets | $781.8M | $414.1M | $431.7M | $473.7M | $446.1M | |
| Property Plant And Equipment | $69.5M | $81.5M | $72M | $75M | $65.1M | |
| Long-Term Investments | $5.2M | $8.7M | $32M | $23.6M | $25.9M | |
| Goodwill | $622.8M | $2.2B | $2.2B | $2.3B | $2.4B | |
| Other Intangibles | $53.7M | $329M | $284M | $236.4M | $202.8M | |
| Other Long-Term Assets | $51.8M | $59.8M | $68M | $75.7M | $83.2M | |
| Total Assets | $1.6B | $3.2B | $3.2B | $3.4B | $3.4B | |
| Accounts Payable | $15.9M | $19.1M | $28.8M | $23.6M | $24.5M | |
| Accrued Expenses | $33.7M | $34.7M | $36.7M | $34.6M | $68.9M | |
| Current Portion Of Long-Term Debt | -- | $5M | $6.3M | $10M | -- | |
| Current Portion Of Capital Lease Obligations | $15.9M | $17M | $14.1M | $11.2M | $11.7M | |
| Other Current Liabilities | $179.2M | $207.5M | $267.8M | $373.1M | -- | |
| Total Current Liabilities | $526.5M | $612.8M | $719.8M | $837.8M | $906M | |
| Long-Term Debt | $672.6M | $1.9B | $1.7B | $1.4B | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $2.7B | $2.6B | $2.4B | $2.3B | |
| Common Stock | $2.7M | $2.9M | $2.9M | $3M | $3M | |
| Other Common Equity Adj | -$35.4M | -$75.3M | -$89.4M | -$92.6M | -$97.6M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $704K | $704K | $107K | |
| Total Equity | $354M | $457.7M | $614.2M | $932.6M | $1.1B | |
| Total Liabilities and Equity | $1.6B | $3.2B | $3.2B | $3.4B | $3.4B | |
| Cash and Short Terms | $569.5M | $129.6M | $93.6M | $141.6M | $83.6M | |
| Total Debt | $672.6M | $1.9B | $1.7B | $1.4B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $126.5M | $93.2M | $174.8M | $326.8M | $234.4M | |
| Depreciation & Amoritzation | $36.1M | $52.8M | $71.5M | $71.9M | $64.6M | |
| Stock-Based Compensation | $32.1M | $49M | $75.2M | $73M | $74.4M | |
| Change in Accounts Receivable | $12.4M | -$35.5M | -$60.9M | -$5.2M | -$32.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $258.3M | $288M | $274.3M | $416.7M | $435.3M | |
| Capital Expenditures | $16.4M | $17.5M | $18.5M | $25M | $14M | |
| Cash Acquisitions | -$93M | -$1B | -$743M | -$26M | -$130.4M | |
| Cash From Investing | -$117.3M | -$1.1B | -$770.1M | -$60.5M | -$143.3M | |
| Dividends Paid (Ex Special Dividend) | -$422.6M | -$33.4M | -$34.5M | -$58.8M | -$72.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $675.9M | $2.2B | $833.3M | $588.2M | $517.6M | |
| Long-Term Debt Repaid | -$667.1M | -$991.3M | -$494.7M | -$846.7M | -$664.4M | |
| Repurchase of Common Stock | -$84M | -$120.5M | -$71.8M | -$58.9M | -$76.9M | |
| Other Financing Activities | -$2M | -$59.8M | -$7.9M | -$4.5M | -$9.4M | |
| Cash From Financing | -$136.5M | $982.6M | $243M | -$359.1M | -$289.9M | |
| Beginning Cash (CF) | $121.1M | $122M | $329.3M | $71.7M | $68.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.5M | $214M | -$252.8M | -$2.9M | $2.2M | |
| Ending Cash (CF) | $122M | $329.3M | $71.7M | $68.4M | $64M | |
| Levered Free Cash Flow | $241.9M | $270.5M | $255.8M | $391.7M | $421.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $57M | $56.4M | $45.5M | $70.3M | $91.3M | |
| Depreciation & Amoritzation | $9M | $17.2M | $18.1M | $16.4M | $15.6M | |
| Stock-Based Compensation | $8.9M | $15.1M | $19.5M | $19.7M | $17.4M | |
| Change in Accounts Receivable | $14.9M | $8.7M | $15.4M | $14.5M | $14.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $132.8M | $101.7M | $176.2M | $205M | $219.4M | |
| Capital Expenditures | $2.7M | $4.2M | $4.3M | $3.6M | $3M | |
| Cash Acquisitions | -$58M | -$696M | -$10.3M | -- | -- | |
| Cash From Investing | -$60.6M | -$700.6M | -$20.8M | -$3.8M | -$3M | |
| Dividends Paid (Ex Special Dividend) | -$8.2M | -$8.5M | -$14.5M | -$17.9M | -$21.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $688.8M | $563.9M | $117.1M | $39.8M | $122.2M | |
| Long-Term Debt Repaid | -$262.1M | -$124.9M | -$224.4M | -$134.4M | -$267.4M | |
| Repurchase of Common Stock | -$18.8M | -$35.1M | -$20.9M | -$23.1M | -$39.5M | |
| Other Financing Activities | -$29.3M | -$2.8M | -$295K | -$498K | -$359K | |
| Cash From Financing | $372.1M | $399.9M | -$134.2M | -$126.4M | -$200.8M | |
| Beginning Cash (CF) | $122M | $329.3M | $71.7M | $68.4M | $64M | |
| Foreign Exchange Rate Adjustment | $3.2M | -$807K | $662K | -$1.5M | $4.1M | |
| Additions / Reductions | $444.3M | -$198.9M | $21.2M | $74.7M | $15.6M | |
| Ending Cash (CF) | $569.5M | $129.6M | $93.6M | $141.6M | $83.6M | |
| Levered Free Cash Flow | $130.1M | $97.6M | $171.9M | $201.4M | $216.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $153.9M | $92.6M | $163.9M | $351.6M | $255.5M | |
| Depreciation & Amoritzation | $37.1M | $61M | $72.4M | $70.2M | $63.9M | |
| Stock-Based Compensation | $39.4M | $55.2M | $79.6M | $73.1M | $72.2M | |
| Change in Accounts Receivable | -$11M | -$41.7M | -$54.2M | -$6.1M | -$32.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $318.5M | $257M | $348.8M | $445.4M | $449.7M | |
| Capital Expenditures | $14.6M | $19.1M | $18.7M | $24.3M | $13.5M | |
| Cash Acquisitions | -$111.7M | -$1.7B | -$57.3M | -$15.7M | -$130.4M | |
| Cash From Investing | -$132.7M | -$1.7B | -$90.3M | -$43.6M | -$142.5M | |
| Dividends Paid (Ex Special Dividend) | -$423.1M | -$33.7M | -$40.5M | -$62.1M | -$75.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $2.1B | $386.5M | $510.9M | $600.1M | |
| Long-Term Debt Repaid | -$795.5M | -$854.2M | -$594.1M | -$756.7M | -$797.4M | |
| Repurchase of Common Stock | -$98.8M | -$136.9M | -$57.6M | -$61.1M | -$93.2M | |
| Other Financing Activities | -$31.2M | -$33.3M | -$5.5M | -$4.7M | -$9.3M | |
| Cash From Financing | $321.5M | $1B | -$291.1M | -$351.3M | -$364.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $507.3M | -$429.2M | -$32.6M | $50.6M | -$56.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $303.9M | $237.9M | $330.2M | $421.1M | $436.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $57M | $56.4M | $45.5M | $70.3M | $91.3M | |
| Depreciation & Amoritzation | $9M | $17.2M | $18.1M | $16.4M | $15.6M | |
| Stock-Based Compensation | $8.9M | $15.1M | $19.5M | $19.7M | $17.4M | |
| Change in Accounts Receivable | $14.9M | $8.7M | $15.4M | $14.5M | $14.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $132.8M | $101.7M | $176.2M | $205M | $219.4M | |
| Capital Expenditures | $2.7M | $4.2M | $4.3M | $3.6M | $3M | |
| Cash Acquisitions | -$58M | -$696M | -$10.3M | -- | -- | |
| Cash From Investing | -$60.6M | -$700.6M | -$20.8M | -$3.8M | -$3M | |
| Dividends Paid (Ex Special Dividend) | -$8.2M | -$8.5M | -$14.5M | -$17.9M | -$21.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $688.8M | $563.9M | $117.1M | $39.8M | $122.2M | |
| Long-Term Debt Repaid | -$262.1M | -$124.9M | -$224.4M | -$134.4M | -$267.4M | |
| Repurchase of Common Stock | -$18.8M | -$35.1M | -$20.9M | -$23.1M | -$39.5M | |
| Other Financing Activities | -$29.3M | -$2.8M | -$295K | -$498K | -$359K | |
| Cash From Financing | $372.1M | $399.9M | -$134.2M | -$126.4M | -$200.8M | |
| Beginning Cash (CF) | $122M | $329.3M | $71.7M | $68.4M | $64M | |
| Foreign Exchange Rate Adjustment | $3.2M | -$807K | $662K | -$1.5M | $4.1M | |
| Additions / Reductions | $444.3M | -$198.9M | $21.2M | $74.7M | $15.6M | |
| Ending Cash (CF) | $569.5M | $129.6M | $93.6M | $141.6M | $83.6M | |
| Levered Free Cash Flow | $130.1M | $97.6M | $171.9M | $201.4M | $216.4M | |
Get BSY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BSY
Sector
P/E ratio
72.89x
23.75x
PEG ratio
0.37x
0.00x
P/B ratio
15.92x
2.35x
Price / LTM sales
13.87x
1.66x
Growth Metrics
BSY
Sector
Revenue growth
9.71%
3.91%
Earnings growth
27.27%
11.1%
Revenue (5-year growth)
12.93%
6.27%
Earnings forecast
$0.29
$0.12
Profitability
BSY
Sector
Profitability FY 2024
$1.1B
$76.5M
Return on invested capital
10.74%
0.05%
Return on assets
7.61%
-0.48%
Return on equity
25.13%
0.73%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
6
Balance Sheet
BSY
Sector
Total cash
$83.6M
$48.7M
Short term investments
--
$19.4M
Total assets
$3.4B
$223.8M
Long term debt
$1.2B
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
